Taro Common Stock Shares Outstanding from 2010 to 2024
| TARO Stock | USD 42.39 0.09 0.21% |
Common Stock Shares Outstanding | First Reported 1987-03-31 | Previous Quarter 37.6 M | Current Value 37.6 M | Quarterly Volatility 11.2 M |
Check Taro Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Taro main balance sheet or income statement drivers, such as Total Revenue of 356.7 M, Gross Profit of 235.8 M or Other Operating Expenses of 670.4 M, as well as many exotic indicators such as Price To Sales Ratio of 2.36, Dividend Yield of 0.0 or PTB Ratio of 3.72. Taro financial statements analysis is a perfect complement when working with Taro Pharmaceutical Valuation or Volatility modules.
Taro | Common Stock Shares Outstanding |
Latest Taro Pharmaceutical's Common Stock Shares Outstanding Growth Pattern
Below is the plot of the Common Stock Shares Outstanding of Taro Pharmaceutical Industries over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Taro Pharmaceutical's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Taro Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Shares Outstanding | 10 Years Trend |
|
Common Stock Shares Outstanding |
| Timeline |
Taro Common Stock Shares Outstanding Regression Statistics
| Arithmetic Mean | 38,598,122 | |
| Geometric Mean | 37,183,185 | |
| Coefficient Of Variation | 21.17 | |
| Mean Deviation | 4,754,794 | |
| Median | 40,155,087 | |
| Standard Deviation | 8,171,293 | |
| Sample Variance | 66.8T | |
| Range | 32.9M | |
| R-Value | 0.09 | |
| Mean Square Error | 71.3T | |
| R-Squared | 0.01 | |
| Significance | 0.75 | |
| Slope | 167,337 | |
| Total Sum of Squares | 934.8T |
Taro Common Stock Shares Outstanding History
About Taro Pharmaceutical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Taro Pharmaceutical income statement, its balance sheet, and the statement of cash flows. Taro Pharmaceutical investors use historical funamental indicators, such as Taro Pharmaceutical's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although Taro Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Taro Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Taro Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Taro Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Taro Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 43.2 M | 32.2 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Taro Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Taro Pharmaceutical's short interest history, or implied volatility extrapolated from Taro Pharmaceutical options trading.
Currently Active Assets on Macroaxis
When determining whether Taro Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taro Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taro Pharmaceutical Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taro Pharmaceutical Industries Stock:Check out the analysis of Taro Pharmaceutical Correlation against competitors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Taro Stock analysis
When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.782 | Earnings Share 1.22 | Revenue Per Share 16.252 | Quarterly Revenue Growth 0.129 | Return On Assets 0.0103 |
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.